California 2021-2022 Regular Session

California Assembly Bill AB1178

Introduced
2/18/21  
Introduced
2/18/21  
Refer
3/4/21  
Report Pass
4/27/21  
Report Pass
4/27/21  
Refer
4/29/21  
Refer
4/29/21  
Refer
5/12/21  
Refer
5/12/21  
Failed
2/1/22  

Caption

Medi-Cal: serious mental illness: drugs.

Impact

If passed, AB 1178 would amend the Welfare and Institutions Code to change existing Medi-Cal regulations regarding the dispensing of medication for serious mental illnesses. By allowing pharmacists to dispense a 90-day supply of medications and approve early refills under specific conditions, the bill aims to ensure that patients maintain access to their vital medications, thereby reducing the risk of treatment interruptions and improving overall mental health outcomes.

Summary

Assembly Bill 1178, introduced by Assembly Member Irwin, aims to enhance access to prescription medications for individuals diagnosed with serious mental illnesses under the Medi-Cal program. The bill proposes to eliminate the prior authorization requirement for any drug prescribed for the treatment of a serious mental illness for a period of up to 180 days from the date of the initial prescription. This measure is intended to streamline the approval process, making it easier for patients to continue their treatment without unnecessary bureaucratic obstacles.

Sentiment

The sentiment surrounding AB 1178 has been largely positive among health advocates and professionals who see it as a critical step toward addressing the needs of individuals with serious mental health issues. Supporters argue that simplifying the prescription approval process would enhance patient compliance and outcomes. However, there may be concerns regarding the potential for increased medication access without adequate monitoring, which opponents believe could lead to misuse or insufficient oversight.

Contention

Nonetheless, the bill does face some contention, particularly regarding the safeguards that are integral to the proper management of medications for mental health conditions. Critics may argue that the removal of prior authorization could overlook the importance of evaluating a patient's ongoing need for specific medications or monitoring potential side effects. Balancing access to necessary medications with appropriate safety measures remains an essential consideration in discussions about the bill.

Companion Bills

No companion bills found.

Similar Bills

CA AB3285

Medi-Cal: antipsychotic drugs.

CA SB621

Health care coverage: biosimilar drugs.

HI SB760

Relating To Psychologists.

HI SB131

Relating To Psychologists.

HI SB760

Relating To Psychologists.

HI SB677

Relating To Prescriptive Authority For Clinical Psychologists.

HI SB1295

Relating To Prescriptive Authority For Certain Clinical Psychologists.

HI SB708

Relating To Prescriptive Authority For Clinical Psychologists.